kaiyun(Öйú)¹Ù·½ÍøÕ¾-¿ªÔÆÌåÓý¹Ù·½Èë¿Ú

¡¾Âö²¬Ò½Ò©¡¿MedBio|38748-32-2|Triptolide¼¼Êõ×ÊÁÏ

2021-05-07

TriptolideÖÐÎıðÃû£º À×ÌÙËØ¼×£¬ À×¹«ÌÙÄÚõ¥´¼

1¡¢TriptolideÎïÀí²ÎÊý£º

³£ÓÃÃû

À×¹«ÌÙ¼×ËØ

Ó¢ÎÄÃû

Triptolide

CASºÅ

38748-32-2

·Ö×ÓÁ¿

360.401

ÃܶÈ

1.5¡À0.1 g/cm3

·Ðµã

601.7¡À55.0 ¡ãC at 760 mmHg

·Ö×Óʽ

C20H24O6

ÈÛµã

226-227¡ãC

ÉÁµã

220.7¡À25.0 ¡ãC

 

 

 

2¡¢TriptolideÎïÀí»¯Ñ§ÐÔÖÊ£º

ÃÜ¶È 1.5¡À0.1 g/cm3
·Ðµã 601.7¡À55.0 ¡ãC at 760 mmHg
ÈÛµã 226-227¡ãC
·Ö×Óʽ C20H24O6
·Ö×ÓÁ¿ 360.401
ÉÁµã 220.7¡À25.0 ¡ãC
¾«È·ÖÊÁ¿ 360.157288
PSA 84.12000
LogP 1.27
Íâ¹ÛÐÔ×´ °×É«ÖÁ»Ò°×É«¹ÌÌå
ÕôÆûѹ 0.0¡À3.9 mmHg at 25¡ãC
ÕÛÉäÂÊ 1.647
´¢´æÌõ¼þ

ÃܱÕÓÚ2-8 ?CÒõÁ¹¸ÉÔï»·¾³ÖÐ

Îȶ¨ÐÔ

×ñÕչ涨ʹÓúʹ¢´æÔò²»»á·Ö½â¡£

Ë®ÈܽâÐÔ DMSO: soluble
·Ö×ӽṹ

1¡¢ Ħ¶ûÕÛÉäÂÊ£º88.32

2¡¢ Ħ¶ûÌå»ý£¨m3/mol£©£º242.9

3¡¢ µÈÕűÈÈÝ£¨90.2K£©£º681.3

4¡¢ ±íÃæÕÅÁ¦£¨dyne/cm£©£º61.8

5¡¢ ¼«»¯ÂÊ£¨10 -24cm 3£©£º35.01

¼ÆË㻯ѧ

1¡¢ ÊèË®²ÎÊý¼ÆËã²Î¿¼Öµ£¨XlogP£©£º0.2

2¡¢ Çâ¼ü¹©ÌåÊýÁ¿£º1

3¡¢ Çâ¼üÊÜÌåÊýÁ¿£º6

4¡¢ ¿ÉÐýת»¯Ñ§¼üÊýÁ¿£º1

5¡¢ ÍØÆË·Ö×Ó¼«ÐÔ±íÃæ»ý£¨TPSA£©£º84.1

6¡¢ ÖØÔ­×ÓÊýÁ¿£º26

7¡¢ ±íÃæµçºÉ£º0

8¡¢ ¸´ÔÓ¶È£º819

9¡¢ Í¬Î»ËØÔ­×ÓÊýÁ¿£º0

10¡¢ È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿£º9

11¡¢ ²»È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿£º0

12¡¢ È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿£º0

13¡¢ ²»È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿£º0

14¡¢ ¹²¼Û¼üµ¥ÔªÊýÁ¿£º1

3¡¢Triptolide¼¼Êõ×ÊÁÏ£º

ÌåÍâÑо¿

À×¹«ÌÙÄÚõ¥´¼ÓÕµ¼ÅàÑøµÄºÍÔ­·¢ÐÔÂýÐÔÁܰÍϸ°û°×Ѫ²¡£¨CLL£©Bϸ°ûµòÍö¡£ÓÃÀ×¹«ÌÙÄÚõ¥´¼´¦ÀíCD19 + Bϸ°ûÓÕµ¼ÅàÑøµÄºÍÔ­´úCLLϸ°ûÖÐϸ°ûµòÍöµÄ¼ÁÁ¿ÒÀÀµÐÔÔö¼Ó¡£À×¹«ÌÙÄÚõ¥¶Ô¸ß·çÏÕ£¨n = 5£©ºÍµÍ·çÏÕCLL£¨n = 12£©Bϸ°û£¨10ÖÁ50nM·¶Î§£©¾ßÓÐÑ¡ÔñÐÔ¶¾ÐÔ£¬Í¬Ê±´ó²¿·Ö±£ÁôÕý³£Bϸ°û£¨n = 5£©¡£ÓëÈÈÐÝ¿ËÓÕµ¼µÄHSPת¼µÄÒÖÖÆÒ»Ö£¬ÓÃÀ×¹«ÌÙÄÚõ¥´¼ÖÎÁƿɼõÇáÈÈÐÝ¿ËÓÕµ¼µÄHSPs±í´ï[1]¡£À×¹«ÌÙÄÚõ¥ÊÇÒ»ÖÖÀ´×ÔÖйúÖ²ÎïÀ×¹«ÌÙ£¨Tripterygium wilfordii£©µÄÌìÈ»²úÎ¾Ý±¨µÀÆäÔڹ㷺µÄ°©Ö¢ÖоßÓп¹Ö×Áö×÷Óá£À×¹«ÌÙÄÚõ¥ÒÔ¼ÁÁ¿ÒÀÀµÐÔ·½Ê½ÒÖÖÆMDM2±í´ï£¬¼´Ê¹ÔÚ¼±ÐÔÁܰÍϸ°û°×Ѫ²¡£¨ALL£©Ï¸°ûÖпçÔ½20-100nMµÄµÍŨ¶ÈÒ²ÊÇÈç´Ë¡£À×¹«ÌÙÄÚõ¥ÔÚ¾ßÓÐÌìÈ»MDM2¹ý±í´ïµÄËùÓÐ8ÖÖϸ°ûϵÖбíÏÖ³öÇ¿ÁÒµÄϸ°û¶¾»îÐÔ£¬IC50Öµ·¶Î§Îª47ÖÁ73nM¡£À×¹«ÌÙÄÚõ¥¶Ô±í´ï·Ç³£µÍˮƽµÄMDM2µÄEU-4ϸ°û±íÏÖ³ö¸üÉÙµÄϸ°û¶¾ÐÔ×÷Ó㬶øµ±MDM2Îȶ¨×ªÈ¾Ê±ËüÓÐЧµØÉ±ËÀÕâЩϸ°û£¨IC50Öµ£º725nM¶Ô88nM£©[2]¡£½«·Ö»¯µÄPC12ϸ°ûÓ벻ͬŨ¶ÈµÄÀ×¹«ÌÙÄÚõ¥£¨0.01,0.1ºÍ1nM£©ÔÚ10¦ÌMA¦Â25-35´æÔÚÏ·õÓý24Сʱ£¬²¢Ê¹ÓÃMTT²â¶¨·¨¼ì²âÀ×¹«ÌÙÄÚõ¥´¼µÄ×÷Ó᣽á¹ûÏÔʾA¦Â25-35¿É½µµÍϸ°û»îÁ¦£¬µ±ÓÃÀ×¹«ÌÙÄÚõ¥´¼´¦Àíʱ£¬·Ö»¯µÄPC12ϸ°ûµÄ»îÁ¦ÏÔ×ÅÔö¼Ó¡£½á¹û±íÃ÷£¬À×¹«ÌÙÄÚõ¥¿ÉÒÔ¼õÇáA¦Â25-35ÒýÆðµÄϸ°ûËðÉË£¬ÕâÒâζ×ÅÀ×¹«ÌÙÄÚõ¥¾ßÓÐÉñ¾­±£»¤×÷ÓÃ[3]¡£

ÌåÄÚÑо¿

½ÓÊܾ²ÂöÄÚ¼ÁÁ¿ºó£¬À×¹«ÌÙÄÚõ¥£¨TP£©Ñª½¬Å¨¶ÈÔÚСÊóÖÐѸËÙϽµ¡£×¢Éä2Сʱºó£¬À×¹«ÌÙÄÚõ¥Å¨¶È½µÖÁµÍÓÚËùÓÐÈý×éµÄ¶¨Á¿ÏÂÏÞ¡£ÔÚ¶ÔÕÕ×éºÍÖÎÁÆ×éÖ®¼ä½øÐвÎÊý±È½Ï£¬ÒÔÆÀ¹ÀP-gpÒÖÖÆ¶ÔÀ×¹«ÌÙÄÚõ¥´¼±©Â¶ºÍÏû³ýµÄÓ°Ïì¡£ÓÃmdr1a-siRNA´¦Àí¿ÉÏÔ×ÅÔöÇ¿À×¹«ÌÙÄÚõ¥Ñª½¬±©Â¶£¬Cmax´Ó413¡À74Ôö¼Óµ½510¡À94 ng / mL£¨P <0.05£©£¬AUC´Ó103.5¡À9.6Ôö¼Óµ½154.3¡À30.2 ng?h / mL £¨P <0.05£©¡£ÔÚ°éËæTariquidarµÄͬʱ£¬AUCÏÔ×ÅÔö¼Ó£¬´Ó¶ÔÕÕµÄ103.5¡À9.6µ½À×¹«ÌÙÄÚõ¥+ Tariquidar×éµÄ145.9¡À24.6 ng?h / mL£¨P <0.05£©¡£Òò´Ë£¬Ð¡ÊóÀ×¹«ÌÙÄÚõ¥µÄ×ÜÌåÇå³ýÂÊÏÔ×ÅϽµ£¬´Ó¶ÔÕÕµÄ9564¡À1024.2 mL / min / kg½µÖÁ6576.4¡À1438.5£¨P <0.05£©ºÍ5755.4¡À1200.1 mL / min / kg£¨P <0.05£©¡£À×¹«ÌÙÄÚõ¥+ TariquidarºÍTriptolide + mdr1a-siRNA×é·Ö±ðΪ[4]¡£

 

4¡¢TriptolideͬÀà²úÆ·Áбí£º

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13620

Piceatannol

Piceatannol

10083-24-6

10mM (in 1mL DMSO)

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13559

IKK¦Å-IN-1

IKK¦Å-IN-1

1292310-49-6

5mg

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13610

Phosphatase Inhibitor Cocktail 1 (100X in DMSO)

Phosphatase Inhibitor Cocktail 1 (100X in DMSO)

None

10x1ml

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13543

HG-9-91-01

HG-9-91-01

1456858-58-4

2mg

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13548

IMD 0354

IMD 0354

978-62-1

10mg

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13544

Resiquimod (R-848)

Resiquimod (R-848)

144875-48-9

10mM (in 1mL DMSO)

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13599

(¡À)-Lisofylline

(¡À)-Lisofylline

6493-06-7

10mg

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13578

Ro 106-9920

Ro 106-9920

62645-28-7

50mg

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13566

Pam2CSK4

Pam2CSK4

868247-72-7

1mg

¡Ý98%

Æ·ÅÆ

»õºÅ

ÖÐÎÄÃû³Æ

Ó¢ÎÄÃû³Æ

CAS

°ü×°

´¿¶È

MedBio

MED13577

MK 886

MK 886

118414-82-7

10mg

¡Ý98%

5¡¢TriptolideÓ¢ÎıðÃû£º

MFCD00210565
(3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-6-Hydroxy-6a-isopropyl-8b-methyl-3b,4,4a,6,6a,7a,7b,8b,9,10-decahydrotrisoxireno[6,7:8a,9:4b,5]phenanthro[1,2-c]furan-1(3H)-one
(3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1(3H)-one
triptolid
Triptolide (PG490)
EINECS 300-006-3
(3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-6-hydroxy-8b-methyl-6a-(propan-2-yl)-3b,4,4a,6,6a,7a,7b,8b,9,10-decahydrotrisoxireno[6,7:8a,9:4b,5]phenanthro[1,2-c]furan-1(3H)-one
(3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-6a-isopropyl-8b-methyltrisoxireno[6,7:8a,9:4b,5]phenanthro[1,2-c]furan-1(3H)-one
TRIPTOLIDE TLC
Triptolide
Trisoxireno[6,7:8a,9:4b,5]phenanthro[1,2-c]furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, (3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-
Triptolide(PG490)
,7as,7bs,8as,8bs)
PG490
triptergium wilfordii

 

6¡¢Triptolide²Î¿¼ÎÄÏ×£º

Biological activity and safety of Tripterygium extract prepared by sodium carbonate extraction.
Molecules 17(9) , 11113-23, (2012)
Condensin targets and reduces unwound DNA structures associated with transcription in mitotic chromosome condensation.
Nat. Commun. 6 , 7815, (2015)
Cardiosphere-derived cells from pediatric end-stage heart failure patients have enhanced functional activity due to the heat shock response regulating the secretome.
Stem Cells 33(4) , 1213-29, (2015)

»õºÅ ²úÆ·Ãû³Æ Æ·ÅÆ ¹æ¸ñÐͺаü×° Ŀ¼¼Û ÊýÁ¿ ¹ºÎï³µ
MED80115 À×¹«ÌÙ¼×ËØ ,38748-32-2 MedBio ¡Ý99% 5mg ?950.00
MED80115 À×¹«ÌÙ¼×ËØ ,38748-32-2 MedBio ¡Ý99% 25mg ?3500.00
MED80115 À×¹«ÌÙ¼×ËØ ,38748-32-2 MedBio ¡Ý99% 10mg ?1350.00
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿